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Shiga toxin (Stx) binding sites in porcine tissues and leukocytes were identified by the use of Stx overlay and
anti-CD77/Gb3 immunoassays. Stx1 and Stx2 bound to similar tissue locations and leukocytes, although some
differences were noted. Previously unreported Stx binding sites were identified in kidney tubules, intestinal
lymphoid aggregates, sinusoidal liver cells, alveolar macrophages, and peripheral blood leukocytes.
Shiga toxin (Stx)-producing Escherichia coli (STEC) strains,
including STEC O157:H7, cause diarrhea, hemorrhagic colitis,
and hemolytic-uremic syndrome in humans (26). All STEC
strains produce one or more Shiga toxins (Stx1 or Stx2) which
mediate damage in the kidney, colon, and brain (26). All Stx
types can bind to glycolipid receptors called globotriaosylcer-
amides (Gb3) (26). Stx2-producing strains are more frequently
associated with severe disease than are strains that produce
only Stx1 or both Stx1 and Stx2 (2, 8). The mechanisms of
Stx-mediated tissue damage are not fully understood.
A primary mechanism of Stx-mediated damage is direct Stx
cytotoxicity for vascular endothelial (9, 24) and renal epithelial
(16) cells. Proposed indirect mechanisms include Stx-induced
vascular damage and ischemia (26), Stx-induced immuno-
modulation (5), Stx-induced activation of platelets (17), and
Stx transport by leukocytes (32, 34). Several lines of evidence
indicate that leukocytes are involved in Stx-mediated damage.
Stx1 binds to isolated human (28, 32, 34) and bovine (30)
leukocytes, and Stx binding suppresses the activation and pro-
liferation of lymphocytes from some cattle (10, 20) and induces
the production of proinflammatory mediators by human mono-
cytes (28, 34). These mediators may contribute to endothelial
cell damage by inducing the localization and activation of poly-
morphonuclear cells (PMN) (11) or by sensitizing endothelial
cells to Stx cytotoxicity (31). Stx also binds to isolated human
PMN, which may deliver Stx to target cells (32).
The identification of Stx binding sites is a key step toward
elucidating the mechanisms of Stx-induced damage. Pigs are
an ideal model for Stx binding studies because they are sus-
ceptible to natural (23) and experimental (12, 18, 33) Stx-
mediated disease and develop typical Stx-mediated vascular
lesions (6, 7, 14, 33). Pig tissues contain Gb3 and bind Stx (3,
14), and Stx binding correlates with gross tissue levels of Gb3
(3).
Information about the locations of Stx binding sites in por-
cine tissues is limited mostly to vascular and endothelial sites
(14, 27). The only direct comparison of Stx1 and Stx2 binding
to porcine tissues was done with ileal tissues (27). Stx binding
to mononuclear cells in the ileal lamina propria (27), Stx
toxicity for alveolar macrophages (21), and STEC-induced
changes in lymphoid tissue in gnotobiotic pigs (5) provide
indirect evidence that Stx also binds to porcine leukocytes. The
objectives of this study were to (i) identify Stx1 and Stx2 bind-
ing sites in porcine tissues and (ii) determine if Stx binds to
porcine leukocytes.
Stx binding sites and Gb3 were identified by immunoassays
with frozen tissues (kidney, ileum, cerebellum, liver, spiral co-
lon, and cecum from three pigs and jejunum from two pigs)
obtained from 4-day-old cesarean section-derived, co-
lostrum-deprived or naturally farrowed, colostrum-fed pigs.
These tissues were available from pigs used for other studies at
the National Animal Disease Center (NADC), Ames, Iowa.
None of the pigs had been infected with Stx-producing E. coli.
Frozen tissue sections were cut and fixed in undiluted acetone
and then cryopreserved (27).
Stx1 and Stx2 binding sites in frozen porcine tissues were
identified by use of an Stx overlay assay (27) which was mod-
ified for porcine tissues as noted below. Tissue sections were
sequentially incubated with affinity-purified Stx1 or Stx2 (pro-
vided by Alison O’Brien, Uniformed Services University of the
Health Sciences, Bethesda, Md.) diluted to 3.5 and 3.0 g/ml,
respectively, with monoclonal (anti-Stx1 Mab13C4 or anti-Stx2
Mab11E10) (provided by James Samuel, Texas A&M Univer-
sity, College Station, Tex.) or polyclonal rabbit anti-Stx2 (Ali-
son O’Brien) antibodies diluted in normal goat serum (Kirkeg-
aard & Perry Laboratories [KPL], Gaithersburg, Md.), and
with biotin-streptavidin-alkaline phosphatase detection re-
agents. The following modifications were incorporated: (i)
Tris-buffered saline (TBS; 0.1 M Tris, 120 mM NaCl, pH 7.6)
was used instead of 0.1 M Tris, (ii) hybridization covers (Grace
Bio-Labs, Bend, Oreg.) were used for all incubations, except
for those with the substrate, and (iii) biotinylated reagents
were supplemented with normal swine serum (NSS; in-house
reagent, used at a 10% [vol/vol] final concentration). Stx2 bind-
ing was also assayed by use of a 10-fold higher concentration of
Stx2 (30 g/ml) and polyclonal anti-Stx2. Negative control
sections were incubated with TBS instead of Stx or with het-
erologous primary antibodies. Bound Stx appeared as a red
precipitate against the blue counterstained background.
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The distribution of Gb3 in frozen porcine tissues was deter-
mined by immunostaining with anti-CD77/Gb3 (14). Tissue
sections were sequentially incubated (1 h at 37°C) with rat
monoclonal anti-CD77/Gb3 (diluted 1:10 in TBS) (Accurate
Chemical, Westbury, N.Y.), biotinylated goat anti-rat immu-
noglobulin M (IgM; diluted 1:200 in TBS with 10% [vol/vol]
NSS) (KPL), alkaline phosphatase conjugate (KPL), and His-
toMark Red substrate (KPL). Control sections were incubated
with a rat IgM isotypic control (1:10; Accurate Chemical) in-
stead of anti-CD77/Gb3.
Stx binding was detected in all tissues tested, and the results
were similar for tissues from colostrum-deprived and co-
lostrum-fed pigs. Although staining reactions with polyclonal
anti-Stx2 were more intense than those with monoclonal anti-
Stx2, both antibodies stained similar sites. Both Stx1 and Stx2
bound to immature glomeruli in the outer cortex; to tubules,
mature glomeruli, vessels, and arterioles in the inner cortex
(Fig. 1B and C); to capillaries and meninges in the cerebellum;
to vascular cells surrounding ducts and sinusoidal cells (most
likely Kupffer cells) within the parenchyma in the liver (Fig.
1D); to cells in the lamina muscularis mucosae, muscle cells,
and individual cells within the lamina propria of all intestinal
sites examined; to Peyer’s patches and smooth muscle near the
Peyer’s patches in the ileum (Fig. 1G); and to lymphoid aggre-
gates in the jejunum, spiral colon, and cecum. In addition, Stx1
bound to some sites where Stx2 did not bind, namely, mucosal
and serosal blood vessels in the ileum and spiral colon and
small blood vessels in the liver. Anti-CD77/Gb3 bound to all
sites where Stx bound (e.g., compare Fig. 1A to 1B and C) and
also to nerve fibrils in the cerebellar white matter (Fig. 1E),
which was a site where neither Stx toxin bound (Fig. 1F).
The Stx overlay and anti-CD77/Gb3 assays were modified
for indirect immunofluorescence detection and were used to
determine if Stx can bind to isolated porcine tissue leukocytes
and if these cells contain Gb3. For these studies, alveolar
macrophages obtained from three 4- to 12-week-old pigs by
lung lavage (22) (provided by A. Vorwald and S. Brockmeier,
NADC) were seeded onto eight-chambered slides (Nalgene
Nunc, Rochester, N.Y.) at a density of 4  104 cells/slide
chamber, incubated (2 h, 37°C, 5% CO2), rinsed with phos-
phate-buffered saline (PBS), fixed by a brief (1 s) immersion
in 60% (vol/vol) acetone-PBS, and stored at 80°C.
For Stx binding, alveolar macrophage slides were incubated
with Stx2, rabbit anti-Stx2 (as described above), and fluores-
cein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG
(1:80; Sigma, St. Louis, Mo.). For Gb3, the slides were incu-
bated with anti-CD77/Gb3 (as described above) and FITC-
conjugated goat anti-rat IgM (1:20; Southern Biotechnology,
Birmingham, Ala.). Hanks’ balanced salt solution without
Ca2 or Mg2 (HBSS) and HBSS containing 1% fetal bovine
serum (HyClone, Logan, Utah) were used for wash steps and
reagent dilutions, respectively. Negative controls were incu-
bated with dilution buffer instead of Stx2 or with heterologous
antibodies instead of anti-Stx2 or anti-CD77/Gb3. Slides were
examined under an Eclipse E800 microscope (Nikon Instru-
ments, Inc., Melville, N.Y.) with FITC filters (excitation, 465 to
495 nm; emission, 515 to 555 nm). Cells with bound Stx2 or
anti-CD77/Gb3 fluoresced green. Stx2 and anti-CD77/Gb3
bound to 80% of the alveolar macrophages on all evaluated
slides. No green fluorescence was seen on negative control
slides.
Indirect immunofluorescence assays were also used to de-
termine if Stx bound to peripheral blood leukocytes (PBL) and
if PBL contained Gb3. Blood samples were collected in hep-
arin from three adult pigs (6 months old) on 2 days. Gran-
ulocyte and mononuclear leukocyte fractions were isolated
(within 2 h of sample collection) by density gradient centrifu-
gation with Ficoll-sodium diatrizoate (Amersham Pharmacia
Biotech, Piscataway, N.J.) (13). Red blood cells were removed
from granulocyte fractions by hypotonic lysis. Fractions were
adjusted to 107 cells/ml in RPMI 1640 (Life Technologies,
Gaithersburg, Md.) containing 4% autologous serum (mono-
nuclear leukocytes) or 10% fetal bovine serum (granulocytes).
Direct smears (10 to 15 l/slide; 105 cells) were prepared on
glass slides, fixed in 60% acetone-PBS, 1.5% formalin, or 100%
methanol or by air drying, and stored (for up to 1 year) at the
ambient temperature. In preliminary studies, Stx2 bound sim-
ilarly to PBL fixed in 60% acetone-PBS or 1.5% formalin or by
air drying, but it did not bind to cells that were fixed in 100%
methanol. The cellular morphology was maintained better on
air-dried smears, so these were used for all studies reported
here. Differential staining showed that mononuclear leukocyte
fractions contained 95% mononuclear cells (4% mono-
cytes) and that granulocyte fractions contained 90% granu-
locytes (64 to 86% PMN and 8 to 35% eosinophils).
Stx2 and anti-CD77/Gb3 binding was evaluated for duplicate
PBL smears from each of six blood draws by use of the immu-
nofluorescence assays described above for alveolar macro-
phages. Stx1 binding was evaluated for PBL smears from a
single blood draw by the use of crude Stx1 (29) (provided by
Nancy Cornick, Iowa State University, Ames, Iowa), anti-Stx1
Mab13C4, and FITC-conjugated goat anti-mouse IgG (Vector,
Burlingame, Calif.) (diluted 1:10 in HBSS containing 10%
[vol/vol] NSS). At least 600 cells per granulocyte smear and 20
high-power fields (HPFs; each containing 30 to 50 cells) per
mononuclear leukocyte smear were examined for fluorescence.
The results were calculated as the percentages of green fluo-
rescent cells on granulocyte smears or the total numbers of
fluorescent cells/20 HPFs on mononuclear leukocyte smears.
The numbers of cells and cellular morphologies in the fields
examined for fluorescence were determined by differential in-
terference contrast microscopy (Fig. 2). Eosinophils were dif-
ferentiated from PMN by their red autofluorescence when the
slides were examined with tetramethyl rhodamine isothiocya-
nate filters (excitation, 528 to 563 nm; emission, 600 to 660 nm)
(1).
As shown in Fig. 2, Stx1, Stx2, and anti-CD77/Gb3 bound to
similar numbers of cells on PBL smears. On granulocyte
smears, 58 to 91% of the cells examined were positive. All
positive granulocytes were PMN (i.e., none of the positive
granulocytes fluoresced red when examined with tetramethyl
rhodamine isothiocyanate filters), and for each sample the
percentage of positive cells correlated with the percentage of
PMN, as determined by differential counts. On mononuclear
leukocyte smears, 10 cells/HPF were positive, and positive
cells were morphologically identified as monocytes. The num-
ber of positive cells correlated with the number of monocytes
by differential counts, providing further evidence that Stx and
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anti-CD77/Gb3 bound to monocytes but not to lymphocytes.
No green fluorescence was observed on negative control slides.
In this study, we showed that Stx1 and Stx2 bound to similar
locations in multiple porcine tissues, although some differences
were noted. We identified some novel porcine Stx binding
sites, including kidney tubules, intestinal lymphoid aggregates,
sinusoidal cells in the liver, and isolated leukocytes. The ob-
servation that Stx bound to porcine kidney tubules, as it does
to bovine (15, 27) and human (19) kidney tubules, is consistent
with the presence of kidney tubule damage in pigs that are
experimentally infected with STEC (6, 14) and with the sensi-
tivity of human kidney proximal tubule epithelial cells to Stx
FIG. 1. Immunohistochemical identification of Stx binding sites and Gb3 in neonatal porcine tissues. Anti-CD77/Gb3 (A), Stx1 (B), and Stx2
(C) binding to tubules (arrows) and glomeruli (arrowheads) in sections of the kidney (g, glomerulus) are shown. (D) Stx2 binding to endothelial
cells lining a vessel (thick arrow) and sinusoidal cells within the parenchyma (thin arrow) of the liver. Anti-CD77/Gb3 (E), but not Stx1 (F), binding
to nerve fibrils in the white matter (arrowheads) of the cerebellum was observed. (G) Stx2 binding within a Peyer’s patch (thin arrow), to smooth
muscle (arrowhead), and to cells within the villous lamina propria (thick arrows) in the ileum. Digital images were captured directly with a Digital
Spot RT Slider camera (Diagnostic Instruments, Inc., Sterling Heights, Mich.) using MetaVue, version 5.0.7, imaging software (Universal Imaging
Corp., Downingtown, Pa.). Bar  50 m.
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(16). Although intestinal lymphoid aggregates and liver cells
are not recognized as targets for Stx-mediated damage, these
tissues might be involved in Stx-induced immunomodulation or
transport or in the clearance of Stx. We did not identify any
unique Stx2 binding sites that correlated with the enhanced
virulence associated with Stx2. In fact, Stx1 bound to more
vascular sites than Stx2 did (even when Stx2 was tested at
10-fold higher concentrations and detected with polyclonal
anti-Stx2 antibodies). Nonetheless, it cannot be ruled out that
discrepancies between Stx1 and Stx2 binding were due to dif-
ferences in the sensitivities of the immunohistochemical assays
because of differences in the relative binding affinities of the
reagents (which were not assessed in this study) or differences
in the form of Stx receptors in the various tissues (4).
This study provided direct evidence that Stx can bind to
porcine leukocytes. Stx bound to PBL (monocytes and granu-
locytes), to tissue leukocytes (alveolar macrophages), and to
tissue locations where leukocytes reside (i.e., the intestinal
lamina propria, intestinal lymphoid aggregates, and the liver).
These results are consistent with reports that Stx binds to
human PMN and monocytes (28, 32, 34) and to bovine intes-
tinal lymphoid aggregates (15) and with the demonstration that
liver and splenic macrophages are involved in Stx2 cytotoxicity
in mice (25). We hypothesize that Stx binding to leukocytes is
involved in STEC disease pathogenesis in pigs.
Our results extend the evidence that Stx binds to Gb3 re-
ceptors in porcine tissues (3) and that not all Gb3 molecules
are Stx receptors (4). The distribution of Stx binding sites
correlated with the distribution of Gb3 in porcine tissues and
leukocytes. The immunohistochemical detection of Gb3 at all
sites where Stx bound confirmed earlier reports of Gb3 detec-
tion by high-performance liquid chromatography (HPLC) in
the porcine liver, colon, and kidney (3) and by thin-layer chro-
matography in the kidney (14). The detection of Gb3 in the
cerebellum, a site at which Gb3 was not detected by HPLC (3),
suggests that the anti-CD77/Gb3 immunoassay may be more
sensitive than HPLC for detecting Gb3 and disputes the notion
that acetone fixation removes Gb3 from porcine tissues (15).
To our knowledge, this is the first report of anti-CD77/Gb3
binding to cerebellar nerve fibrils. Although we did not detect
Stx binding to nerve fibrils, Stx may have bound at levels below
the detection limit of our assay.
Porcine peripheral blood leukocytes and the Stx binding
assays described in this report will be useful for studying Stx
binding mechanisms and for evaluating the effects of Stx bind-
ing on leukocyte functions. An advantage of using porcine
leukocytes for these studies is that porcine STEC infection
models are available for testing the relevance of the in vitro
findings.
We thank B. K. Wheeler for technical assistance; J. F. Pohlenz for
consultation, advice, and a critical review of the manuscript; and
NADC Visual Services and S. L. Johnson for preparation of the manu-
script.
FIG. 2. Indirect immunofluorescent detection of Stx binding and Gb3 on porcine peripheral blood leukocytes. Anti-CD77/Gb3 (A), Stx1 (B),
and Stx2 (C) binding to cells on granulocyte smears are shown. Anti-CD77/Gb3 (E), Stx1 (F), and Stx2 (G) binding to cells on mononuclear
leukocyte smears are also shown. (D and H) Differential interference contrast illumination of the same fields as those in panels C and G,
respectively. Images were obtained as described in the legend to Fig. 1. Bar  25 m.
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